JIANG Bin, PANG Yan-bin. PhaseⅡClinical Study of Erlotinib for Treatment of Myelodysplastic Syndromes[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 86-88. DOI: 10.3969/j.issn.1671-5144.2015.02.009
|
Citation:
|
JIANG Bin, PANG Yan-bin. PhaseⅡClinical Study of Erlotinib for Treatment of Myelodysplastic Syndromes[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 86-88. DOI: 10.3969/j.issn.1671-5144.2015.02.009
|
JIANG Bin, PANG Yan-bin. PhaseⅡClinical Study of Erlotinib for Treatment of Myelodysplastic Syndromes[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 86-88. DOI: 10.3969/j.issn.1671-5144.2015.02.009
|
Citation:
|
JIANG Bin, PANG Yan-bin. PhaseⅡClinical Study of Erlotinib for Treatment of Myelodysplastic Syndromes[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 86-88. DOI: 10.3969/j.issn.1671-5144.2015.02.009
|
DownLoad: